Luke van Hengel

Luke Van Hengel is an accomplished executive with a career-long history of success in business management and financial operations within the pharmaceutical industry. He is currently the Executive Vice President of Strategic Pricing, Commercial Operations and Strategy at Parexel International, where he is responsible for developing and maintaining the framework for Parexel’s commercial strategy. In this role, Luke has been instrumental in driving the company's growth and profitability through his strategic vision and leadership.

Luke has a strong background in financial analysis, account management, sales support, budgeting, deal-making, and contracts management. He is an effective relationship builder and has expertise in establishing strategic partnerships with key stakeholders. Throughout his career, Luke has demonstrated a keen ability to identify and capitalize on business opportunities, leading to significant revenue growth and increased market share for his organizations.

Luke holds a Bachelor of Arts in Business Administration from the University of Southern California, a Master of Business Administration in International Management from the European University, and has completed a postgraduate course in Clinical Pharmacology, Drug Development, and Regulation at Tufts University. His education and training have provided him with a strong foundation in business and finance, as well as a deep understanding of the pharmaceutical industry.